← Back to catalogue

RVS-200, NIBP (Riester) +SpO2 (Riester)

FDA UDI

Class I (US FDA UDI)

by Rudolf Riester GmbH & Co. KG

Identity

Trade Name
RVS-200, NIBP (Riester) +SpO2 (Riester) FDA UDI
Generic Name
Automatic-inflation electronic sphygmomanometer, non-portable FDA UDI
Device Name
The RVS-200 Wall Diagnostic Station and RVS-200 Extension Module were produced for use with various instrument heads for non-invasive diagnosis of ENT and Ophthalmology. FDA UDI
Model / Reference
1961-RRXXU FDA UDI
Description
The RVS-200 Wall Diagnostic Station and RVS-200 Extension Module were produced for use with various instrument heads for non-invasive diagnosis of ENT and Ophthalmology. FDA UDI

Identifiers

Catalog Number
1961-RRXXU FDA UDI
Primary DI / UDI-DI
04045396216334 FDA UDI
FDA Product Code
ERA FDA UDI
GMDN Term
Automatic-inflation electronic sphygmomanometer, non-portable FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
874.4770 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Automatic-inflation electronic sphygmomanometer, non-portable

RVS-200, NIBP (Riester) +SpO2 (Riester) by Rudolf Riester GmbH & Co. KG — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Automatic-inflation electronic sphygmomanometer, non-portable.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI a3443b9e-a392-4666-b951-62a16a575409 34 fields · synced Jun 8, 2026